SS Innovations Names Sarah M. Romano CFO

By Philip Seaworth • Tuesday, July 14 10:53 • Permanent Link

SS Innovations International has named Sarah M. Romano as chief financial officer, effective Aug. 3, 2026, as the company prepares for its next phase of expansion.

Romano brings more than 20 years of finance experience in medtech and life sciences. At Vicarious Surgical, she led efforts to reduce cash burn and strengthen the balance sheet. Before that, she served as CFO of Entero Therapeutics and Kiora Pharmaceuticals, where she handled capital raising, strategic transactions, SEC reporting and investor relations.

Across her career, Romano has raised more than $100 million through public and private financings. She is also a former PricewaterhouseCoopers auditor and a licensed CPA in Massachusetts.

For SS Innovations, the hire comes as the company is pushing global expansion and pursuing U.S. FDA approval for its SSI Mantra surgical robotic system. The company describes the platform as a cost-effective robotic surgery system, alongside its SSI Mudra surgical instruments, which are used across procedures including cardiac surgery. Following these announcements, the company's shares moved 3.02%, and are now trading at a price of $3.75. For the full picture, make sure to review SS Innovations International's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.